Healionics Corporation, a developer of synthetic biomaterial-based medical devices, today announced that its STARgraft arteriovenous graft – designed to provide a safer and more reliable means of bloodstream access for…
MedTechVets, a leading non-profit organization dedicated to supporting military veterans in transitioning into careers in the medical technology sector, proudly announces a new executive leadership program for graduates of the…
MedTechVets, a leading non-profit organization dedicated to supporting military veterans in transitioning into careers in the medical technology sector, proudly announces the appointment of Scott Whitaker to our Board of Directors effective…
MedTechVets, a leading non-profit organization dedicated to supporting military veterans in transitioning into careers in the medical technology sector, proudly announces the appointment of Ramzi Nuwayhid as Board Director effective…
Healionics Corporation, a developer of synthetic biomaterial-based medical devices, today announced 12-month clinical results in the ongoing human trial of its STARgraft arteriovenous (AV) graft (NCT05729620). STARgraft is a new…
Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced the U.S. Food and Drug Administration (FDA) has approved the company’s Shield™ blood test for colorectal cancer (CRC)…
MedTechVets, a leading non-profit organization dedicated to supporting military veterans in transitioning into careers in the medical technology sector, proudly announces Mary McLoughlin will be consulting as Strategic Advisor effective…
Neuspera Medical, Inc., a neuromodulation company pioneering the Neuspera Implantable Sacral Neuromodulation (SNM) System, announced the closing of its Series D funding round raising $23 million and led by Vertex…
The Wisconsin Biohealth Tech Hub, led by BioForward Wisconsin, achieves a significant milestone as a Phase 2 recipient of the U.S. Department of Commerce’s Economic Development Administration (EDA) Regional Technology…
UroMems, a global company developing innovative, implantable mechatronics technology to treat stress urinary incontinence (SUI), today announced it has raised $47 million in its Series C financing, the largest fundraising…